KNOTT DAVID M - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 214 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 0.96 and the average weighting 0.3%.

Quarter-by-quarter ownership
KNOTT DAVID M ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2017$21,000
-97.6%
550
-98.2%
0.01%
-97.5%
Q2 2017$863,000
-54.3%
30,947
-43.7%
0.36%
-60.4%
Q1 2017$1,889,000
-0.7%
54,947
-16.7%
0.91%
-5.0%
Q4 2016$1,902,000
-8.6%
65,947
+0.8%
0.96%
-10.9%
Q3 2016$2,080,000
-99.9%
65,397
-0.3%
1.07%
+118.7%
Q2 2016$2,129,279,000
+1284.6%
65,597
+1092.7%
0.49%
+1097.6%
Q1 2016$153,780,000
-84.7%
5,500
-82.1%
0.04%
-81.0%
Q1 2015$1,003,772,000
-31.0%
30,800
-32.8%
0.22%
-37.0%
Q4 2014$1,454,150,000
+28.2%
45,8000.0%0.34%
+58.8%
Q3 2014$1,134,008,000
+9.6%
45,8000.0%0.22%
+16.8%
Q2 2014$1,034,622,000
-7.2%
45,8000.0%0.18%
-13.1%
Q1 2014$1,114,314,000
-2.6%
45,8000.0%0.21%
-8.6%
Q4 2013$1,144,542,000
-16.7%
45,800
-8.4%
0.23%
-11.4%
Q3 2013$1,373,500,000
+51.3%
50,0000.0%0.26%
+39.2%
Q2 2013$907,500,00050,0000.19%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
March Altus Capital Management LP 82,723$2,685,00020.75%
HWG Holdings LP 289,380$9,393,0008.72%
Baker Brothers Advisors 24,516,738$795,813,0008.34%
HARVEY CAPITAL MANAGEMENT INC 352,200$11,432,0005.73%
Belmont Global Advisors, Inc. 150,000$4,869,0004.67%
Palo Alto Investors LP 1,437,730$46,669,0003.52%
Avoro Capital Advisors LLC 329,500$10,696,0002.38%
GARRISON BRADFORD & ASSOCIATES INC 70,100$2,275,0002.23%
WEATHERBIE CAPITAL, LLC 401,642$13,037,0001.85%
ACUTA CAPITAL PARTNERS, LLC 85,999$2,792,0001.34%
View complete list of ACADIA PHARMACEUTICALS INC shareholders